-
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
July 13, 2026 20:35 ET | Source: Mesoblast Limited NEW YORK, July 13, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has achieved its target of at least 300 patients treated in the MSB-DR004 pivotal Phase 3 randomized controlled trial of rexlemestrocel-L…
-
Omnigel strengthens its portfolio with the introduction of Omnigel Maxstrong
The new variant is built for individuals whose active routines often lead to repeated muscle and joint discomfort Marks its entry into the 2% diclofenac category to address recurring pain with long-lasting relief MUMBAI, India, July 6, 2026 /PRNewswire/ — Omnigel, Cipla Health’s leading pain relief brand, has announced the launch of Omnigel Maxstrong, its…
-
Rare Neuro Emergency after Spinal Tumor Surgery Turns Critical, Ends in Successful Recovery at Zydus Hospital, Ahmedabad
Mother of two, saved after a whirlwind of physical turmoil AHMEDABAD, India, June 26, 2026 /PRNewswire/ — A 35-year-old woman, mother of one, had persistent lower back pain for a very long time. However, in the second pregnancy the pain became relatively severe where even doctors were unable to administer spinal anaesthesia. She delivered a healthy…
-
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with consistent responses that are higher than those observed in trials of competing agents at the end of their respective parental trials Namely, ~67% of patients treated with SLK…
-
World Regional Anaesthesia and Pain Medicine day Workshop brings the Spotlight on Strengthening Patient Safety Standards
New Delhi, Delhi, India BD (Becton, Dickinson and Company) recently participated as Knowledge Partner at the World Regional Anaesthesia & Pain Medicine (RAPM) Day Workshop. With the objective of reinforcing patient-safety practices in Regional Anaesthesia, BD India/South Asia focused on enabling real-time, hands-on learning for clinicians to advanced spinal anaesthesia solutions and supporting faculty-led live…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
